Pharmaceutical Technology6 小时
MRT-6160 by Monte Rosa Therapeutics for Multiple Sclerosis: Likelihood of Approval
MRT-6160 is under clinical development by Monte Rosa Therapeutics and currently in Phase I for Multiple Sclerosis.